Open original FDA record ↗Recall record
- FDA identifier
- Z-2100-2025
- Company in FDA record
- Neurovision Medical Products Inc
- FDA classification date
- Jul 9, 2025
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Product packaging contains the wrong part number and kit contents.
Source facts
- Action
- On May 20, 2025, Neurovision Medical Products (NMP) sent consignees an email notifying them of the recall. On June 10, 2025, NMP followed up with "Urgent Medical Device Recall Notice" dated May 27, 2025, via US postal mail. Neurovision asked consignees to take the following actions: 1. Review your inventory for affected lots. 2. Quarantine product. 3. Cease distribution and use of any affected product. 4. Pass this notice on to all who need to be aware within your organization and/or to any organization where the potentially affected product has been transferred or distributed. 5. Complete and return the enclosed response form as soon as possible via email: customer_service@neurovisionmedical.com or Fax to: (877) 330-1727. 6. NMP Customer Service will respond with a return authorization (RMA) number and return shipping label for any remaining stock. 7. If you have distributed this product to another location or entity, notify them of this product recall (include a copy of this notice), and contact NMP Customer Service for return authorization (RMA). If you have any questions, contact NMP Customer service at (866) 815-6999. NMP Days/Hours Available: Monday through Friday, 8am-4pm (Pacific) and Website: neurovisionmedical.com
- Initiated
- 2025-05-19
- Root cause
- Process control
- Distribution
- US distribution to CA only
- Recall number
- Z-2100-2025
- Recall status
- Open, Classified
- CDRH record ID
- 214092
- FDA classified
- 2025-07-09
- Recall event number
- 96956